Litcius/Paper detail

TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition

Sarah Chiang, Varshini Vasudevaraja, Jonathan Serrano, Colin J.R. Stewart, Esther Oliva, Amir Momeni Boroujeni, Achim A. Jungbluth, Arnaud Da Cruz Paula, Edaise M. da Silva, Britta Weigelt, Kay J. Park, Robert A. Soslow, Rajmohan Murali, Lora H. Ellenson, Ryma Benayed, Marc Ladanyi, Nadeem R. Abu‐Rustum, Mark A. Dickson, Seth Cohen, Carol Aghajanian, Martee L. Hensley, Cheng‐Han Lee, Matija Snuderl, Jason Konner

2021Modern Pathology39 citationsDOIOpen Access PDF

Topics & Concepts

Cancer researchBiologyEndometrial stromal sarcomaPathologyEpigeneticsSarcomaStromal cellMedicineGeneticsGeneUterine Myomas and TreatmentsTuberous Sclerosis Complex ResearchRenal and related cancers
TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition | Litcius